Related Experiment Video

Updated: Apr 27, 2026

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection
09:43

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

8.5K

Fatal pulmonary complications in an immunodeficient child with chronic active Epstein-Barr virus infection

Aleksandra Szczawińska-Popłonyk1, Katarzyna Jończyk-Potoczna, Lidia Ossowska

  • 1ola@malwa.com.pl.

Pneumonologia I Alergologia Polska
|June 26, 2014
PubMed

Insights

Chronic active Epstein-Barr virus infection (CAEBV) can cause severe lung disease in children. This rare complication led to fatal pneumopathy in a pediatric patient, highlighting CAEBV

Area of Science:

  • Pediatric Pulmonology
  • Infectious Diseases
  • Immunology

Background:

  • Primary Epstein-Barr virus infection (EBV) commonly causes infectious mononucleosis in children.
  • Severe pneumonitis is a rare complication in immunocompetent individuals.
  • Chronic active Epstein-Barr virus infection (CAEBV) is linked to severe, life-threatening conditions.

Observation:

  • A pediatric patient with CAEBV developed severe lung disease.
  • The patient presented with interstitial lung disease characterized by fibrosis and lymphoid infiltrations.
  • The clinical course was rapidly progressive and ultimately fatal.

Findings:

  • CAEBV can manifest as severe pneumopathy in pediatric cases.
  • Lymphoid and lymphohistiocytic infiltrations contribute to lung pathology in CAEBV.
  • This case underscores the potential for severe pulmonary manifestations of CAEBV.

Implications:

  • CAEBV should be considered in pediatric patients with unexplained severe lung disease.
  • Early diagnosis and management of CAEBV may be crucial for improving outcomes.
  • Further research is needed to understand and treat EBV-associated pulmonary complications.

More Related Videos

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis08:44

Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis

Published on: September 7, 2022

2.3K
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

14.6K

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.7K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
4.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
2.4K
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
22
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K